Fact check: Federal law does not prevent states, businesses, employers from requiring COVID-19 vaccines msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
ana santos rutschman, thank you so much. i appreciate it. we ll take a quick break on the program. when we come back, former u.s. president donald trump s big lie about a stolen election is resonating among his supporters. now they re taking another look at election ballots to try to prove his allegations. we ll have that and much more after the break. at t-mobile, we re on our way to hiring 10,000 veterans and military spouses by 2023. and our commitment doesn t stop there. we always offer 50% off family lines on our military and veteran plans. that s right, 50% off on america s most reliable 5g network.
Print this article
The difficulty of learning the technology behind mRNA vaccines poses a major obstacle to President Joe Biden s proposal aiding poor countries by defying the pharmaceutical industry and waiving patent protections for COVID-19 vaccines.
The rationale for the patent waiver would be to allow developing countries to reproduce currently existing COVID-19 vaccines without having to worry about getting sued by the pharmaceutical companies that hold the patents.
But in the case of the mRNA vaccines produced by Pfizer/BioNTech and Moderna, doing so would be very difficult. As of March, mRNA vaccines accounted for 43% of the COVID-19 vaccines produced, according to British software company Airfinity.
Print
The pharmaceutical industry, which thought it had entered the can-do-no-wrong stage of public esteem thanks to its development of COVID-19 vaccines in record time, just got taken down a peg by the Biden administration.
On Wednesday, the administration said it supports waiving patent protections for those same vaccines to help combat the pandemic around the world.
Drugmakers, which were counting on lavish profits from the vaccines, squealed like stuck pigs. Phrma, their leading trade group, called the policy “an unprecedented step that will undermine our global response to the pandemic and compromise safety.”
This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures.
Listen to the story.
Canada s Minister of Public Services and Procurement Anita Anand opens a box with some of the AstraZeneca COVID-19 vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ontario, March 3, 2021. Credit:
Share
For decades, the small Canadian company, Biolyse Pharma, has specialized in making injectable cancer drugs at its plant in St. Catharine’s Ontario.
When the pandemic hit, co-founder Claude Mercure watched from the sidelines as vaccine inequities unfolded globally. He wanted to help.
“We basically have the equipment. We have large bioreactors here that could deal with an industrial production. We should leave no stones unturned.”